International Journal of Cancer
Copyright © 2015 UICC
Editor-in-Chief: Professor Peter Lichter, DKFZ, Germany
Impact Factor: 5.007
ISI Journal Citation Reports © Ranking: 2013: 34/203 (Oncology)
Online ISSN: 1097-0215
Recently Published Issues
Read the Latest from IJC
IJC Accepted Articles(accepted manuscripts)
Accepted Articles have been accepted for publication in IJC, but have not undergone the editing and proof-correction process. Accepted Articles are citable by DOI.
IJC Early View(e-pub ahead of print)
Early View articles are definitive in format and presented in advance of print publication.
View These Special Section Selections
Cancer research in France
Cancer research in France
Kara Rogers and Gilbert M. Lenoir
Oncometabolites-driven tumorigenesis: From genetics to targeted therapy
Aurélie Morin et al.
Recent insights into the biology of neuroblastoma
Gudrun Schleiermacher et al.
Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia
Julien Ablain and Hugues de Thé
Follow us on Facebook for the latest news from IJC:
Professor Lichter's Top Picks
136(9): 1 May 2015
Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients
Jordan Madic et al.
136(8): 15 April 2015
Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model
Eun-Kee Song et al.
136(7): 1 April 2015
Metastasis blood test by flow cytometry: in vivo cancer spheroids and the role of hypoxia
Viktoria Denes et al.
136(6): 15 March 2015
Assessment of ovarian cancer conditions from exhaled breath
Haitham Amal et al.
136(5): 1 March 2015
Identification of predictive factors of response to the BH3-mimetic molecule ABT-737: An ex vivo experiment in human serous ovarian carcinoma
Stéphanie Lheureux et al.
136(4): 15 February 2015
Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma
Mikko Siurala et al.
136(3): 1 February 2015
Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells
Xin Li et al.
136(2): 15 January 2015
Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma
T Chiba et al.
136(1): 1 January 2015
Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival
A. De Remigis et al.
135(12): 15 December 2014
Cell-targeting inhibits that as tumor inflammation an inducing without local dendritic of growth immunoadjuvant lipopeptide a development
T Akazawa et al.
135(11): 1 December 2014
Immunotherapy of B-cell non-Hodgkin lymphoma by targeting the chemokine receptor CXCR5 in a preclinical mouse model
H. Panjideh et al.
2014 Joint IJC & Klaus Tschira Stiftung Lectureships
The Joint IJC and Klaus Tschira Stiftung Lectureship at the German Cancer Research Center (DKFZ) in Heidelberg honors three to four leading scientists in the field of cancer research each year. We would like to offer our international readership a taste of these lectures and now present the 2014 videos. Additional videos will be posted following each lecture. We welcome you to view them. The videos from the lectures in 2012 and 2013 can be found under “Special Features”.
Prof Jane Visvader
The Walter and Eliza Hall Institute Melbourne, Australia
Prof Peter W. Laird
University of Southern California, School of Medicine, CA
Prof Dr C. Richard Boland
Baylor University Medical Center Dallas, Texas